Show simple item record

Malarija stara bolest - novi izazovi

dc.creatorOpsenica, Dejan
dc.creatorOpsenica, Igor
dc.date.accessioned2019-01-30T17:14:44Z
dc.date.available2019-01-30T17:14:44Z
dc.date.issued2006
dc.identifier.issn0440-6826
dc.identifier.urihttp://cer.ihtm.bg.ac.rs/handle/123456789/273
dc.description.abstractMalaria is one of the most deadly diseases in world affecting more than 500 million people with over 2 million deaths per year. Four species of Plasmodium cause human disease: Plasmodium vivax (P. vivax), Plasmodium malarie (P. malarie), Plasmodium ovale (P. ovale) and Plasmodium falciparum (P. falciparum). For the treatment of malaria there is a great number of drugs available, but limiting factors are: high prices, toxicity and increased resistance of parasite. For these reasons there is great need for development of new drugs, increasing control of existing and finding new admission in treatment of malaria.en
dc.publisherSrpsko hemijsko društvo, Beograd
dc.rightsopenAccess
dc.sourceHemijski pregled
dc.titleMalaria ancient disease: New challengesen
dc.titleMalarija stara bolest - novi izazovisr
dc.typearticle
dc.rights.licenseARR
dcterms.abstractОпсеница, Дејан; Опсеница, Игор; Маларија стара болест - нови изазови; Маларија стара болест - нови изазови;
dc.citation.volume47
dc.citation.issue5
dc.citation.spage108
dc.citation.epage113
dc.citation.other47(5): 108-113
dc.identifier.rcubConv_463
dc.identifier.fulltexthttp://cer.ihtm.bg.ac.rs//bitstream/id/8937/271.pdf
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record